| 1 |
28613690 | Statin Medications | 2022 Jan |
1 |
| 2 |
31049523 | Polysaccharides derived from natural sources regulate triglyceride and cholesterol metabolism: a review of the mechanisms. | 2019 May 22 |
1 |
| 3 |
30326043 | Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes. | 2018 Oct 1 |
1 |
| 4 |
28277343 | Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases. | 2017 Apr |
1 |
| 5 |
25605429 | miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR. | 2015 Mar |
2 |
| 6 |
26301579 | Association between the Lipid Levels and Single Nucleotide Polymorphisms of ABCA1, APOE and HMGCR Genes in Subjects with Spontaneous Preterm Delivery. | 2015 |
1 |
| 7 |
23634756 | Investigation of gene-by-sex interactions for lipid traits in diverse populations from the population architecture using genomics and epidemiology study. | 2013 May 1 |
1 |
| 8 |
23731091 | Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance. | 2013 Jun 26 |
1 |
| 9 |
21083855 | Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism. | 2011 Mar |
2 |
| 10 |
20540816 | A single nucleotide polymorphism in the 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene ( HMGCR) influences the serum triacylglycerol relationship with dietary fat and fibre in the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study. | 2010 Sep |
2 |
| 11 |
19327612 | Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. | 2009 Mar |
1 |
| 12 |
19554360 | The HMG-CoA reductase gene and lipid and lipoprotein levels: the multi-ethnic study of atherosclerosis. | 2009 Aug |
1 |
| 13 |
20005478 | The role of HMGCR alternative splicing in statin efficacy. | 2009 Jul |
1 |
| 14 |
18375239 | Safety of niacin and simvastatin combination therapy. | 2008 Apr 17 |
1 |
| 15 |
18395165 | Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia. | 2008 May |
2 |
| 16 |
18559695 | Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. | 2008 Jul 22 |
1 |
| 17 |
18815589 | A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study. | 2008 Dec |
1 |
| 18 |
17317435 | Diabetes and metabolic syndrome (MS). | 2007 |
1 |
| 19 |
14727929 | Combination therapy with an HMG-CoA reductase inhibitor and a fibric acid derivative: a critical review of potential benefits and drawbacks. | 2003 |
2 |
| 20 |
14983743 | [Diabetes and multimetabolic syndrome]. | 2003 Dec |
1 |
| 21 |
12029999 | [Pharmacological effects of HMG-CoA reductase inhibitors]. | 2002 May |
1 |
| 22 |
11452336 | Elevated baseline triglyceride levels modulate effects of HMGCoA reductase inhibitors on plasma lipoproteins. | 2001 Jan |
2 |
| 23 |
11474489 | Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects. | 2001 Aug |
1 |
| 24 |
14728015 | Drug treatment of combined hyperlipidemia. | 2001 |
1 |
| 25 |
10690940 | Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin. | 2000 Feb |
2 |
| 26 |
10710119 | Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels. | 2000 Mar |
1 |
| 27 |
11563401 | Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation. | 1999 Feb |
1 |
| 28 |
8330475 | Evidence of combined therapy of dyslipoproteinemia by HMG-CoA reductase inhibitors and "essential" phospholipids. | 1993 Apr |
1 |
| 29 |
1333628 | Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro. | 1992 Sep |
1 |